AI Rewrites Pharma's Customer Playbook

The pharmaceutical industry is on the cusp of a major customer engagement overhaul, driven by artificial intelligence. It's not just about deploying new software; it's a strategic shift requiring transformed processes and a reimagined workforce. The future of pharma commercial engine is here, demanding a reinvention of how companies connect with their audiences.

AI: The New Engine of Engagement

For decades, the field force has been the linchpin of pharma's success, accounting for up to 70% of impactable sales. However, these teams are increasingly strained by fragmented systems, leading to a critical need for seamless, omnichannel experiences. Recent industry disruptions, like the Veeva, Salesforce split, have highlighted the fragility of existing customer relationship management (CRM) backbones.

Now, AI offers a path forward, making every customer touchpoint smarter, more personal, and better connected. Field teams, eager for enhanced tools, believe AI can significantly elevate their engagement strategies and create more seamless collaboration. This evolution positions AI not merely as an automation tool, but as a core component of a new engagement model.

The Human+AI Workforce

Pharma is entering an era where human expertise and AI capabilities work in tandem. Agentic systems, including AI copilots and digital orchestrators, are fundamentally changing how work gets done. This extends beyond backend task automation to enhancing field engagement, streamlining content workflows, and improving marketing execution. Research indicates that over half of life sciences workforce hours are impactable by these agents, potentially unlocking significant revenue growth and reducing labor costs.

This shift necessitates a reevaluation of job roles, talent management, and competitive advantage. Organizations must move from managing manual tasks to orchestrating systems where humans and machines collaborate effectively. The integration of agentic systems pharma, such as those explored by companies developing advanced AI platforms, is key to this transformation.

AI at the Customer Frontline

Realizing AI's potential requires more than just technology; it hinges on people and processes. Scaling AI adoption means redefining roles, fostering new collaboration models, and retraining teams to work alongside 24/7 AI agents that deliver real-time insights and handle manual execution tasks.

AI is becoming the connective tissue for field teams, marketing departments, and customers. It enables personalized, insight-led engagement that adapts dynamically to customer needs, embedding trust through intelligent systems that learn and guide behavior compliantly.

Transforming Interactions

• Smarter Call Planning: AI tools equip reps with insights, suggest relevant content, guide discussions, and automate note-taking, making every interaction more effective.
• Hyper-Personalized Content: Representatives can instantly tailor materials to specific specialties or patient needs, ensuring relevance and driving impact through feedback loops.
• Silo-Free Collaboration: AI systems break down barriers between sales, medical, and market access teams by surfacing shared insights and engagement history, aligning efforts around customer goals.

Unlocking New Value Horizons

Pharmaceutical companies face a unique opportunity to transcend legacy CRM systems and fragmented engagement models. While challenges exist, the upside is substantial, impacting the entire commercial ecosystem. Modernizing CRM with AI-driven engagement amplifies the effectiveness of the field force, with 76% of healthcare professionals (HCPs) reporting that interactions with field teams positively influence clinical decisions.

The value realization from AI adoption typically occurs in waves. Initial gains focus on automating low-value work and simplifying infrastructure. Subsequent phases improve engagement through personalized interactions and coordinated digital and field touchpoints. The ultimate horizon unlocks new revenue streams via intelligent agents and digital-first models, extending reach and creating differentiated experiences. Companies embracing this transformation are finding ways to simultaneously cut costs and grow impact.

Accenture, with its extensive experience in life sciences commercial transformation, guides clients through embedding AI, redesigning engagement strategies, and navigating complex CRM landscapes. The approach is customized, recognizing that not all companies need to pursue every AI opportunity at once. The path forward is about reinvention, not just re-platforming.